FOLLOW US

  • facebook
  • twitter
Tue

March 9, 2026

$20M Google Case

America November 13, 2023

$20M Google Case : Challenge on Reissue Patents.

In a legal saga entwined with the intricacies of reissue patents and a hefty $20 million infringement verdict, the U.S.…

By Rihem Akkouche

Dallas Cowboys Stadium app lawsuit

America October 19, 2023

Dallas Cowboys Stadium App Patent Lawsuit

In a stunning turn of events, Front Row Technologies LLC, an Albuquerque-based technology firm, has decided to voluntarily dismiss its…

By Rihem Akkouche

Apple Loses Bid For $5M

America October 18, 2023

Apple Loses Bid For $5M : Apple’s $5 Million Bid Denied After Patent Infringement Victory

In a twist of perplexing legal developments, a California federal judge has delivered a stunning blow to tech giant Apple,…

By Rihem Akkouche

Loeb & Loeb

America October 14, 2023

Loeb & Loeb Pushes for $3.4 Million Arbitration Award Confirmation

In a legal showdown that has all the intensity of a high-stakes courtroom drama, prominent multiservice law firm, Loeb &…

By Rihem Akkouche

Cloudera Faces $240M Verdict

America October 14, 2023

Cloudera Faces $240M Verdict in Landmark Patent Case

In a legal showdown of monumental proportions, a Western District of Texas jury delivered a stunning verdict on Friday. The…

By Rihem Akkouche

Broadcom And Apple $1.1B verdict

America October 13, 2023

Broadcom and Apple $1.1B Verdict Lawsuit Seeks Dismissal, Mystery Looms

In a legal twist that leaves onlookers in suspense, the California Institute of Technology and Broadcom jointly requested a California…

By Rihem Akkouche

America October 5, 2023

Google 3rd Jury Trial: Dodges Legal Bullet in High-Stakes Texas Showdown

In what could be likened to a pivotal scene in a legal thriller, a Texas federal judge abruptly halted a…

By Rochdi Rais

Amazon Alexa lawsuit

America September 15, 2023

Federal Court Revives Amazon’s Alexa Lawsuit

In the legal labyrinth of patent infringements, Amazon finds itself facing another formidable challenge as a research university’s allegations reverberate…

By Rochdi Rais

Business August 8, 2020

Takeda loses battle to stop Mylan from selling generic gout drug

Takeda Pharmaceuticals (NYSE: TAK) failed to stop Mylan (NASDAQ: MYL) from selling a generic version of its Colcrys, a treatment…

By Marivic Cabural Summers

Signup for the USA Herald
exclusive Newsletter